Xanthine-oxidase inhibitors and statins in chronic heart failure: Effects on vascular and functional parameters

dc.creatorGreig, Douglas
dc.creatorAlcaíno Gálvez, Hernán Alejandro
dc.creatorCastro Gálvez, Pablo
dc.creatorGarcía Nannig, Lorena
dc.creatorVerdejo, Hugo E.
dc.creatorNavarro, Mario
dc.creatorLópez, Rafael
dc.creatorMellado, Rose Marie
dc.creatorTapia Mamani, Fabiola Karina
dc.creatorGabrielli, Luigi A.
dc.creatorNogerol, Camilo
dc.creatorChiong Lay, Mario
dc.creatorGodoy, Iván
dc.creatorLavandero González, Sergio
dc.date.accessioned2011-08-08T13:41:44Z
dc.date.available2011-08-08T13:41:44Z
dc.date.created2011-08-08T13:41:44Z
dc.date.issued2011-04
dc.identifierJOURNAL OF HEART AND LUNG TRANSPLANTATION 30 (4): 408-413
dc.identifier1053-2498
dc.identifierhttps://repositorio.uchile.cl/handle/2250/121589
dc.description.abstractIncreased oxidative stress in heart failure (HF) leads to inflammation and endothelial dysfunction (ED). Both statins and allopurinol have known anti-oxidant properties, but their utility in HF has not been fully assessed.
dc.languageen
dc.publisherELSEVIER SCIENCE INC
dc.subjectOXIDATIVE STRESS
dc.titleXanthine-oxidase inhibitors and statins in chronic heart failure: Effects on vascular and functional parameters
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución